ADDITION OF PEGINTERFERON ALFA-2a INCREASES HBsAg DECLINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL. (PAS STUDY)

被引：0
作者：
Farag, Mina S. [1 ,2 ]
Fung, Scott K. [1 ]
Van Campenhout, Margo [3 ]
Van Erpecum, Karel J. [4 ]
Wong, David K. H. [1 ]
Boonstra, Andre [5 ]
Verhey, Elke [3 ]
De Man, Robert A. [3 ]
Liem, Kin Seng [1 ,3 ]
Hansen, Bettina E. [1 ,6 ]
Janssen, Harry L. A. [1 ]
机构：
[1] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[5] Erasmus Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
195
引用
收藏
页码：127A / 128A
页数：2
相关论文
共 50 条
  • [31] Incidence and predictors of flares after discontinuing nucleos (t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B: Results from the randomized controlled STOP study
    Liem, Seng
    Fung, Scott
    Wong, David
    Yim, Colina
    Chen, Jenny
    Noureldin, Seham
    Feld, Jordan
    Hansen, Bettina
    Janssen, Harry
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E474 - E474
  • [32] Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B
    van Boemmel, Florian
    Berg, Thomas
    LIVER INTERNATIONAL, 2018, 38 : 90 - 96
  • [33] Discontinuation of Long-Term Nucleos(T)Ide Analogue(S) [Na(S)] Therapy in HBeAg-Negative Chronic Hepatitis B (Chbe-) Patients Without Cirrhosis: A Prospective Study
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Deutsch, Melanie
    Alexopoulou, Alexandra
    Kourikou, Anastasia
    Kontos, Georgios A.
    Manolakopoulos, Spilios
    Hadziyannis, Emilia
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2014, 146 (05) : S964 - S964
  • [34] Discontinuation of Effective Long-Term Nucleos(t)ide Analogue(s) [NA(s)] Treatment in HBeAg-Negative Chronic Hepatitis B (CHBe-) Patients: A Multicenter Ongoing Prospective Study
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Hadziyannis, Emilia
    Kontos, Georgios
    Deutsch, Melanie
    Alexopoulou, Alexandra
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    HEPATOLOGY, 2015, 62 : 1193A - 1193A
  • [35] Adding peginterferon alfa-2a to entecavir increases HBsAg decline and HBeAg clearance - first results from a global randomized trial (ARES study)
    Sonneveld, Milan J.
    Xie, Qing
    Zhang, Ning-Ping
    Zhang, Qin
    Tabak, Fehmi
    Streinu-cercel, Adrian
    Wang, Jiyao
    Idilman, Ramazan
    de Niet, Annikki
    Diculescu, Mircea.
    van Vuuren, Anneke J.
    Verhey, Elke
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2012, 56 : 199A - 200A
  • [36] PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
    Zoutendijk, Roeand
    Hansen, Bettina E.
    van Vuuren, Anneke J.
    Boucher, Charles A.
    Janssen, Harry L.
    HEPATOLOGY, 2010, 52 (04) : 509A - 509A
  • [37] Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy
    Wang, Meng-Lan
    Chen, En-Qiang
    Tao, Chuan-Min
    Zhou, Tao-You
    Liao, Juan
    Zhang, Dong-Mei
    Wang, Juan
    Tang, Hong
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) : 1420 - 1426
  • [38] ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBsAg LEVELS IN HBeAg-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE TREATMENT: THE HERMES STUDY
    Lampertico, P.
    Brunetto, M. R.
    Craxi, A.
    Gaeta, G. B.
    Rizzetto, M.
    Palmieri, G.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S276 - S276
  • [39] Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study
    Lee, I-Cheng
    Yang, Sien-Sing
    Lee, Chieh-Ju
    Su, Chien-Wei
    Wang, Yuan-Jen
    Lan, Keng-Hsin
    Lin, Han-Chieh
    Hou, Ming-Chih
    Peng, Cheng-Yuan
    Huang, Yi-Hsiang
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (07) : 1075 - 1084
  • [40] KINETICS OF HBSAG DECLINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A ACCORDING TO GENOTYPE AND ITS ASSOCIATION WITH SUSTAINED HBSAG CLEARANCE 4 YEARS POST-TREATMENT
    Brunetto, Mourizia
    Bonino, Ferruccio
    Marcellin, Patrick
    Button, Peter
    Batrla, Richard
    HEPATOLOGY, 2008, 48 (04) : 740A - 740A
12345